Elite Pharmaceuticals Inc
ELTP· OTC
Released Feb 13, 2025, after the close
10-Q filed Feb 13, 2025, 44 days after period end · 0001493152-25-006427
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $14.36M | $15.54M | $9.25M | $8.97M |
| Net Income | -$10.89M | $706.35K | $2.97M | $2.28M |
| EPS Diluted |
Elite Pharmaceuticals Inc · CIK 1053369 · Engraved from SEC EDGAR
| -$0.01 |
| $0.00 |
| $0.00 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.